81 related articles for article (PubMed ID: 17931661)
1. Detection of HDM2 and VEGF co-expression in cancer cell lines: novel effect of HDM2 antisense treatment on VEGF expression.
Narasimhan M; Rose R; Karthikeyan M; Rathinavelu A
Life Sci; 2007 Oct; 81(17-18):1362-72. PubMed ID: 17931661
[TBL] [Abstract][Full Text] [Related]
2. Identification of HDM2 as a regulator of VEGF expression in cancer cells.
Narasimhan M; Rose R; Ramakrishnan R; Zell JA; Rathinavelu A
Life Sci; 2008 Jun; 82(25-26):1231-41. PubMed ID: 18504050
[TBL] [Abstract][Full Text] [Related]
3. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
Xiong J; Yang Q; Li J; Zhou S
Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
[TBL] [Abstract][Full Text] [Related]
4. Nutlin3 blocks vascular endothelial growth factor induction by preventing the interaction between hypoxia inducible factor 1alpha and Hdm2.
LaRusch GA; Jackson MW; Dunbar JD; Warren RS; Donner DB; Mayo LD
Cancer Res; 2007 Jan; 67(2):450-4. PubMed ID: 17234751
[TBL] [Abstract][Full Text] [Related]
5. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
6. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
[TBL] [Abstract][Full Text] [Related]
7. Consequences of the inhibition of Hdm2 expression in human osteosarcoma cells using antisense oligonucleotides.
Geiger T; Hüsken D; Weiler J; Natt F; Woods-Cook KA; Hall J; Fabbro D
Anticancer Drug Des; 2000 Dec; 15(6):423-30. PubMed ID: 11716435
[TBL] [Abstract][Full Text] [Related]
8. Identification of spliced variants of the proto-oncogene HDM2 in colorectal cancer.
Yu Z; Zhang B; Cui B; Wang Y; Han P; Wang X
Cancer; 2012 Feb; 118(4):1110-8. PubMed ID: 21761395
[TBL] [Abstract][Full Text] [Related]
9. Targeting chemotherapy-induced VEGF up-regulation by VEGF antisense oligonucleotides in HNSCC cell lines.
Riedel F; Götte K; Goessler U; Sadick H; Hörmann K
Anticancer Res; 2004; 24(4):2179-83. PubMed ID: 15330158
[TBL] [Abstract][Full Text] [Related]
10. Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways.
Fang J; Xia C; Cao Z; Zheng JZ; Reed E; Jiang BH
FASEB J; 2005 Mar; 19(3):342-53. PubMed ID: 15746177
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of antisense oligodeoxynucleotide on expression of vascular endothelia growth factor by human hepatocarcinoma cells.
Qiu MB; Zhang JX; Liu LM; Gong BD; Wu BL; Zhu SS; Wen Y
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):552-7. PubMed ID: 15567744
[TBL] [Abstract][Full Text] [Related]
12. [Effects of VEGF-A/VEGF-C antisense oligodeoxynucleotide on angiogenesis, lymphangiogenesis, and tumor growth of breast cancer].
Chen JS; Zhang YJ; Hu SE; Zhang HQ
Ai Zheng; 2007 Sep; 26(9):972-6. PubMed ID: 17927855
[TBL] [Abstract][Full Text] [Related]
13. Expression of cyclooxygenase-2 in colorectal adenocarcinoma is associated with p53 accumulation and hdm2 overexpression.
Cressey R; Pimpa S; Tontrong W; Watananupong O; Leartprasertsuke N
Cancer Lett; 2006 Feb; 233(2):232-9. PubMed ID: 15921850
[TBL] [Abstract][Full Text] [Related]
14. Hodgkin's lymphoma cells express alternatively spliced forms of HDM2 with multiple effects on cell cycle control.
Sánchez-Aguilera A; García JF; Sánchez-Beato M; Piris MA
Oncogene; 2006 Apr; 25(18):2565-74. PubMed ID: 16331255
[TBL] [Abstract][Full Text] [Related]
15. MNK1 and EIF4E are downstream effectors of MEKs in the regulation of the nuclear export of HDM2 mRNA.
Phillips A; Blaydes JP
Oncogene; 2008 Mar; 27(11):1645-9. PubMed ID: 17828301
[TBL] [Abstract][Full Text] [Related]
16. Reactivation of p53 function in synovial sarcoma cells by inhibition of p53-HDM2 interaction.
D'Arcy P; Ryan BA; Brodin B
Cancer Lett; 2009 Mar; 275(2):285-92. PubMed ID: 19081178
[TBL] [Abstract][Full Text] [Related]
17. Regulation of hdm2 by stress-induced hdm2alt1 in tumor and nontumorigenic cell lines correlating with p53 stability.
Dias CS; Liu Y; Yau A; Westrick L; Evans SC
Cancer Res; 2006 Oct; 66(19):9467-73. PubMed ID: 17018602
[TBL] [Abstract][Full Text] [Related]
18. Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms.
Wang H; Yu D; Agrawal S; Zhang R
Prostate; 2003 Feb; 54(3):194-205. PubMed ID: 12518324
[TBL] [Abstract][Full Text] [Related]
19. GC-selective DNA-binding antibiotic, mithramycin A, reveals multiple points of control in the regulation of Hdm2 protein synthesis.
Phillips A; Darley M; Blaydes JP
Oncogene; 2006 Jul; 25(30):4183-93. PubMed ID: 16501602
[TBL] [Abstract][Full Text] [Related]
20. [VEGF antisense oligonucleotide inhibits the expression of vascular endothelial growth factor in human leukemic cell lines].
Zhang L; Tu ZG; Feng WL; Huang ZG
Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):22-5. PubMed ID: 14990072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
